BnR Summit 2026

Belt & Road Summit - Deal-Making 2026

9 – 15 Sept 2026 | Hong Kong, China (Hong Kong)

Qi Diagnostics Limited

www.qidiagnostics.comChina (Hong Kong)
11 profile visits

About

We are developing a Next Generation Cancer Detection Breathalyzer. It can perform multiple cancers screening and lung cancer specific detection.

We also have a novel handheld breath testing device for cannabis and drug detection.

我们正在研发下一代癌症检测呼气分析仪。可进行多种癌症筛查和肺癌特异性检测。

我们还开发了一种新型的手持呼气测试设备,用于大麻和毒品检测。

Areas of activity

Technology

Health TechnologyMedical Technology

Additional information

Other Place of Business

Hong KongMainland China

Company Funding Stage

Seed & Pre-Series

Terms and Conditions & Disclaimer

I agree

Representatives

Founder & CEO

Qi Diagnostics Limited

Marketplace (2)

  • Project

    Point-of-care Early Cancer Breath Testing

    We are proud to be the first team to develop a cancer-specific breath marker and a POC breathalyzer device with high sensitivity and promising clinical applicability in detecting cancer tumors.

    • No
    • Yes
    • Debt
    • Equity
    • Technology
    • Private Project
    • Health Technology
    • Convertible Loan
    • Equity (private)
    • Medical Technology
    • Financial Services
    • Open for negotiation
    • Open for Negotiation
    • Minority Shareholdings
    • Direct Equity Investment
    • Institutional Investment
    • 2,500,001 to 5,000,000 USD
    • Public / Alternative Financing
    • Private Equity & Venture Capital
    • Investment / Financing Discussion
    Author

    Founder & CEO at Qi Diagnostics Limited

    China (Hong Kong)

  • Project

    Cannabis and Drug Breath Testing

    A novel handheld breath analyzer for cannabis and drug detection.

    • No
    • Yes
    • Debt
    • Equity
    • Technology
    • Joint Venture
    • Private Project
    • Health Technology
    • Convertible Loan
    • Equity (private)
    • Medical Technology
    • Financial Services
    • Open for negotiation
    • Open for Negotiation
    • Professional Services
    • 500,001 to 1,000,000 USD
    • Direct Equity Investment
    • Institutional Investment
    • Feasibility Study Completed
    • Public / Alternative Financing
    • Market Entry Strategic Analysis
    • Private Equity & Venture Capital
    • Public–private partnership / Concession
    Author

    Founder & CEO at Qi Diagnostics Limited

    China (Hong Kong)